Literature DB >> 19335130

Pathophysiology and genetic factors in moyamoya disease.

Achal S Achrol1, Raphael Guzman, Marco Lee, Gary K Steinberg.   

Abstract

Moyamoya disease is an uncommon cerebrovascular condition characterized by progressive stenosis of the bilateral internal carotid arteries with compensatory formation of an abnormal network of perforating blood vessels providing collateral circulation. The etiology and pathogenesis of moyamoya disease remain unclear. Evidence from histological studies, proteomics, and endothelial progenitor cell analyses suggests new theories underlying the cause of vascular anomalies, including moyamoya disease. Familial moyamoya disease has been noted in as many as 15% of patients, indicating an autosomal dominant inheritance pattern with incomplete penetrance. Genetic analyses in familial moyamoya disease and genome-wide association studies represent promising strategies for elucidating the pathophysiology of this condition. In this review, the authors discuss recent studies that have investigated possible mechanisms underlying the etiology of moyamoya disease, including stem cell involvement and genetic factors. They also discuss future research directions that promise not only to offer new insights into the origin of moyamoya disease but to enhance our understanding of new vessel formation in the CNS as it relates to stroke, vascular anomalies, and tumor growth.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19335130     DOI: 10.3171/2009.1.FOCUS08302

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  27 in total

Review 1.  Collaterals: Implications in cerebral ischemic diseases and therapeutic interventions.

Authors:  Yasuo Nishijima; Yosuke Akamatsu; Phillip R Weinstein; Jialing Liu
Journal:  Brain Res       Date:  2015-03-11       Impact factor: 3.252

2.  Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia.

Authors:  Dominique Hervé; Anne Philippi; Reda Belbouab; Michel Zerah; Stéphane Chabrier; Sophie Collardeau-Frachon; Francoise Bergametti; Aurore Essongue; Eliane Berrou; Valérie Krivosic; Christian Sainte-Rose; Emmanuel Houdart; Frédéric Adam; Kareen Billiemaz; Marilyne Lebret; Sabine Roman; Sandrine Passemard; Gwenola Boulday; Audrey Delaforge; Stéphanie Guey; Xavier Dray; Hugues Chabriat; Peter Brouckaert; Maryjke Bryckaert; Elisabeth Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2014-02-27       Impact factor: 11.025

3.  Missing relationship of moyamoya and persistent primitive artery in Europeans. Another distinctive feature or artifact?

Authors:  Holger Wenz; Ralf Wenz; Alex Förster; Johann Fontana; Hans Ulrich Kerl; Christoph Groden; Johann Scharf
Journal:  Surg Radiol Anat       Date:  2015-03-08       Impact factor: 1.246

Review 4.  Consensus statement on current and emerging methods for the diagnosis and evaluation of cerebrovascular disease.

Authors:  Manus J Donahue; Eric Achten; Petrice M Cogswell; Frank-Erik De Leeuw; Colin P Derdeyn; Rick M Dijkhuizen; Audrey P Fan; Rashid Ghaznawi; Jeremy J Heit; M Arfan Ikram; Peter Jezzard; Lori C Jordan; Eric Jouvent; Linda Knutsson; Richard Leigh; David S Liebeskind; Weili Lin; Thomas W Okell; Adnan I Qureshi; Charlotte J Stagg; Matthias Jp van Osch; Peter Cm van Zijl; Jennifer M Watchmaker; Max Wintermark; Ona Wu; Greg Zaharchuk; Jinyuan Zhou; Jeroen Hendrikse
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-17       Impact factor: 6.200

5.  RNF213 rare variants in an ethnically diverse population with Moyamoya disease.

Authors:  Alana C Cecchi; Dongchuan Guo; Zhao Ren; Kelly Flynn; Regie Lyn P Santos-Cortez; Suzanne M Leal; Gao T Wang; Ellen S Regalado; Gary K Steinberg; Jay Shendure; Michael J Bamshad; James C Grotta; Deborah A Nickerson; Hariyadarshi Pannu; Dianna M Milewicz
Journal:  Stroke       Date:  2014-10-02       Impact factor: 7.914

Review 6.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

7.  Medical management of moyamoya disease and recurrent stroke in an infant with Majewski osteodysplastic primordial dwarfism type II (MOPD II).

Authors:  Esra Kılıç; Eda Utine; Sule Unal; Göknur Haliloğlu; Kader Karli Oğuz; Mualla Cetin; Koray Boduroğlu; Yasemin Alanay
Journal:  Eur J Pediatr       Date:  2012-04-17       Impact factor: 3.183

8.  Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya.

Authors:  Snaigune Miskinyte; Matthew G Butler; Dominique Hervé; Catherine Sarret; Marc Nicolino; Jacob D Petralia; Francoise Bergametti; Minh Arnould; Van N Pham; Aniket V Gore; Konstantinos Spengos; Steven Gazal; France Woimant; Gary K Steinberg; Brant M Weinstein; Elisabeth Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2011-05-19       Impact factor: 11.025

9.  Common genetic polymorphisms in moyamoya and atherosclerotic disease in Europeans.

Authors:  Constantin Roder; Vera Peters; Hidetoshi Kasuya; Tsutomu Nishizawa; Yayoi Takehara; Daniela Berg; Claudia Schulte; Nadia Khan; Marcos Tatagiba; Boris Krischek
Journal:  Childs Nerv Syst       Date:  2010-08-06       Impact factor: 1.475

Review 10.  Genetic susceptibility to cerebrovascular disease.

Authors:  David Della-Morte; Francesca Pacifici; Tatjana Rundek
Journal:  Curr Opin Lipidol       Date:  2016-04       Impact factor: 4.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.